Hutch News
Results per Page:
Peripheral neuropathy: When having no pain is a big problem
Chemotherapy-induced nerve damage is common for cancer patients and difficult to treat
Immunotherapy helps retired fisheries biologist get back to normal
Advanced chondrosarcoma – 'shark' cancer – has no standard treatments beyond surgery, but Fred Hutch oncologist explores new option for patient
La receta secreta de Mi Vida Saludable
Del laboratorio Greenlee, Divisiones de Ciencias de la Salud Pública e Investigación Clínica
Dr. Fred Appelbaum receives Lifetime Achievement award
Medical pioneer and longtime Fred Hutch leader honored by American Society for Transplantation and Cellular Therapy
The utility of Survivorship Care Plans for rural cancer survivors
From the Chow Studies Group, Public Health Sciences Division
Assessment of willingness to provide medical aid in dying
From the Loggers and Shen labs, Clinical Research Division
Neutrophils disguise tumors by synthesizing and secreting arginase
From the Houghton lab and collaborating Randolph lab, Clinical Research and Public Health Sciences Divisions
Leader in apheresis and cellular therapy, Dr. Michael Linenberger, retires
As professor emeritus, this respected mentor will continue to contribute to the UW fellowship program
Eight Fred Hutch teams win Evergreen Fund awards
Research projects with commercial partnership potential receive grants of up to $200K
The special sauce recipe to Mi Vida Saludable
From the Greenlee lab, Public Health Sciences and Clinical Research Divisions
Fred Hutch/UW/Seattle Children’s Cancer Consortium breast cancer researchers receive grants
Breast Cancer Research Foundation supports projects including new imaging tracer, better risk prediction for luminal B subtypes, anti-inflammatory vaccine and more
Learning from the past to improve SARS-CoV-2 variant discovery
From Dr. Lue Ping Zhao and collaborating labs, Public Health Sciences, Clinical Research, and Vaccine and Infectious Disease Divisions
New approach could make bone marrow transplantation safer, stronger
Tests prevented relapse, limited GVHD in laboratory models of leukemia, multiple myeloma
Hutch scientists receive $25M to solve breast cancer metastasis
New collaboration will target dormant tumor cells, keeping them asleep (or killing them) so they won’t spread
Are revisions to remdesivir dosing needed for treating SARS-CoV-2?
From the Schiffer lab, Clinical Research and Vaccine and Infectious Disease Divisions
New immunotherapy targets discovered for head and neck cancer
From the Prlic lab, Clinical Research and Vaccine and Infectious Disease Divisions
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
Can estrogen improve vaginal health for postmenopausal women?
From the Fredricks lab, Vaccine and Infectious Disease and Clinical Research Divisions
Optimizing antigen design may improve HIV vaccine efforts
From the Pancera, McElrath and Stamatatos labs, Vaccine and Infectious Disease and Clinical Research Divisions
Dr. Brenda Sandmaier named president of American Society for Transplantation and Cellular Therapy
Transplant immunotherapy physician-scientist will serve 2022-2023 term